J. Joseph Melenhorst

Cleveland Clinic, United States

Vice-Chair, Center for ImmunoTherapy & Precision Immuno-Oncology (CITI)
Director, Cell Therapy & Immuno-Engineering Program
Lerner Research Institute
Cleveland Clinic

Disclosure information not submitted.

Presentation(s):

• Single-cell multi-omics reveals type-2 function in CAR T cells associated with 8-year leukemia remission

  Friday, October 25, 2024
  3:00 PM – 3:15 PM EST